Published in Schizophr Res Cogn on September 01, 2014
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis (1980) 14.25
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res (2004) 5.14
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Measuring emotional intelligence with the MSCEIT V2.0. Emotion (2003) 4.10
Binge drinking in young adults: Data, definitions, and determinants. Psychol Bull (2009) 2.78
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry (2005) 2.14
Cognitive deficits as treatment targets in schizophrenia. Schizophr Res (2004) 1.86
Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry (2000) 1.78
General and specific cognitive deficits in schizophrenia. Biol Psychiatry (2004) 1.64
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv (2009) 1.62
Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr Res (2010) 1.55
Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry (2006) 1.45
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand (2001) 1.16
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.11
Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psychiatry (2001) 1.09
The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res (2011) 1.08
Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study. Psychol Med (2007) 1.07
Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci (1997) 1.02
CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn (2005) 1.00
Substance use and cognition in early psychosis. J Psychiatry Neurosci (2003) 0.98
Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. Community Ment Health J (1999) 0.97
Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophr Bull (2005) 0.93
Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder. Schizophr Res (2007) 0.92
Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up. Schizophr Res (2006) 0.92
Cannabis use and cognition in schizophrenia. Front Hum Neurosci (2009) 0.91
The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res (2007) 0.90
Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr Res (2010) 0.90
Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Psychol Med (2007) 0.88
Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res (1996) 0.88
Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia. J Int Neuropsychol Soc (2006) 0.88
Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. Int J Ment Health Nurs (2004) 0.86
Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia. Psychol Med (2009) 0.84
Neurocognitive functioning of individuals with schizophrenia: using and not using drugs. Schizophr Bull (2013) 0.83
Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder. Schizophr Res (2009) 0.83
Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. Addiction (2008) 0.81
Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia. Int J Geriatr Psychiatry (2006) 0.79